Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Invest New Drugs. 2010 Sep 14;30(2):604–610. doi: 10.1007/s10637-010-9537-9

Table 2.

Incidence and Severity of Cycle 1 Toxicities Considered At Least Possibly Related to Study Drug, for All Patients (Pts)

Toxicity Number of Patients Exhibiting Toxicity Per Dose Level Total
Pts.
(%)
Type Grade 1
mg/hr
2
mg/hr
4
mg/hr
8
mg/hr
12
mg/hr
18
mg/hr
27
mg/hr
40
mg/hr
Anorexia 1 1 2 (6)
2 1
Constipation 1 1 1 (3)
Diarrhea 1 1 1 2 (6)
Fatigue 1 1 2 6 (17)
2 2 1
Fingernail
changes
1 1 1 (3)
Mucositis 1 1 1 (3)
Insomnia 1 1 1 (3)
Nausea 1 1 1 1 3 (9)
Pain 1 1 1 (3)